Global Adeno-Associated Virus (AAV) Gene Therapy Market Growth (Status and Outlook) 2026-2032
The global Adeno-Associated Virus (AAV) Gene Therapy market size is predicted to grow from US$ 2031 million in 2025 to US$ 3703 million in 2032; it is expected to grow at a CAGR of 9.1% from 2026 to 2032.
United States market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adeno-Associated Virus (AAV) Gene Therapy players cover Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Adeno-Associated Virus (AAV) Gene Therapy Industry Forecast? looks at past sales and reviews total world Adeno-Associated Virus (AAV) Gene Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Adeno-Associated Virus (AAV) Gene Therapy sales for 2026 through 2032. With Adeno-Associated Virus (AAV) Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adeno-Associated Virus (AAV) Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adeno-Associated Virus (AAV) Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adeno-Associated Virus (AAV) Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Adeno-Associated Virus (AAV) Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adeno-Associated Virus (AAV) Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adeno-Associated Virus (AAV) Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Adeno-Associated Virus (AAV) Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Adeno-Associated Virus (AAV) Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Adeno-Associated Virus (AAV) Gene Therapy players cover Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics, StrideBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Adeno-Associated Virus (AAV) Gene Therapy Industry Forecast? looks at past sales and reviews total world Adeno-Associated Virus (AAV) Gene Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Adeno-Associated Virus (AAV) Gene Therapy sales for 2026 through 2032. With Adeno-Associated Virus (AAV) Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adeno-Associated Virus (AAV) Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Adeno-Associated Virus (AAV) Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adeno-Associated Virus (AAV) Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Adeno-Associated Virus (AAV) Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adeno-Associated Virus (AAV) Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adeno-Associated Virus (AAV) Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Adeno-Associated Virus (AAV) Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Luxturna
- Zolgensma
- Others
- Central Nervous System Diseases
- Ocular Diseases
- Liver-directed Diseases
- Other Hereditary Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Creative Biolabs
- Affinia Therapeutics
- Spark Therapeutics
- AGC Biologics
- StrideBio
- SIRION Biotech
- Neurophth Biotechnology
- Belief BioMed
- BiBo Biopharma Engineering Co., LTD.
- Beihai Kangcheng
- PackGene Biotech
- Sarepta Therapeutics
- Carbon BioSciences
- Kelonia Therapeutics
- Roche
- Remedium Bio
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (2021-2032)
2.1.2 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Adeno-Associated Virus (AAV) Gene Therapy by Country/Region (2021, 2025 & 2032)
2.2 Adeno-Associated Virus (AAV) Gene Therapy Segment by Type
2.2.1 Luxturna
2.2.2 Zolgensma
2.2.3 Others
2.2.4 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
2.2.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
2.3 Adeno-Associated Virus (AAV) Gene Therapy Segment by Application
2.3.1 Central Nervous System Diseases
2.3.2 Ocular Diseases
2.3.3 Liver-directed Diseases
2.3.4 Other Hereditary Diseases
2.3.5 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
2.3.5.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
3 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET SIZE BY PLAYER
3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Player
3.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2021-2026)
3.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY BY REGION
4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026)
4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
4.4 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
4.5 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026)
5.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
5.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026)
6.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
6.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026)
7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy by Region (2021-2026)
8.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET FORECAST
10.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.1.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2.2 Canada Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2.3 Mexico Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2.4 Brazil Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.3.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.2 Japan Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.3 Korea Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.4 Southeast Asia Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.5 India Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.6 Australia Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.2 France Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.3 UK Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.4 Italy Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.5 Russia Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5.2 South Africa Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5.3 Israel Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5.4 Turkey Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.6 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Type (2027-2032)
10.7 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Information
11.1.2 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Creative Biolabs Main Business Overview
11.1.5 Creative Biolabs Latest Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Information
11.2.2 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Affinia Therapeutics Main Business Overview
11.2.5 Affinia Therapeutics Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Information
11.4.2 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 AGC Biologics Main Business Overview
11.4.5 AGC Biologics Latest Developments
11.5 StrideBio
11.5.1 StrideBio Company Information
11.5.2 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 StrideBio Main Business Overview
11.5.5 StrideBio Latest Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Information
11.6.2 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SIRION Biotech Main Business Overview
11.6.5 SIRION Biotech Latest Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Information
11.7.2 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Neurophth Biotechnology Main Business Overview
11.7.5 Neurophth Biotechnology Latest Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Information
11.8.2 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Belief BioMed Main Business Overview
11.8.5 Belief BioMed Latest Developments
11.9 BiBo Biopharma Engineering Co., LTD.
11.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
11.9.2 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BiBo Biopharma Engineering Co., LTD. Main Business Overview
11.9.5 BiBo Biopharma Engineering Co., LTD. Latest Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Information
11.10.2 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Beihai Kangcheng Main Business Overview
11.10.5 Beihai Kangcheng Latest Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Information
11.11.2 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 PackGene Biotech Main Business Overview
11.11.5 PackGene Biotech Latest Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Information
11.12.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sarepta Therapeutics Main Business Overview
11.12.5 Sarepta Therapeutics Latest Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Information
11.13.2 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Carbon BioSciences Main Business Overview
11.13.5 Carbon BioSciences Latest Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Information
11.14.2 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kelonia Therapeutics Main Business Overview
11.14.5 Kelonia Therapeutics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Information
11.16.2 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Remedium Bio Main Business Overview
11.16.5 Remedium Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size (2021-2032)
2.1.2 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Adeno-Associated Virus (AAV) Gene Therapy by Country/Region (2021, 2025 & 2032)
2.2 Adeno-Associated Virus (AAV) Gene Therapy Segment by Type
2.2.1 Luxturna
2.2.2 Zolgensma
2.2.3 Others
2.2.4 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type
2.2.4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
2.3 Adeno-Associated Virus (AAV) Gene Therapy Segment by Application
2.3.1 Central Nervous System Diseases
2.3.2 Ocular Diseases
2.3.3 Liver-directed Diseases
2.3.4 Other Hereditary Diseases
2.3.5 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application
2.3.5.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
3 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET SIZE BY PLAYER
3.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Player
3.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2021-2026)
3.1.2 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player (2021-2026)
3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY BY REGION
4.1 Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026)
4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Annual Revenue by Country/Region (2021-2026)
4.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
4.4 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
4.5 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
4.6 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026)
5.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
5.3 Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026)
6.2 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
6.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026)
7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy by Region (2021-2026)
8.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026)
8.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ADENO-ASSOCIATED VIRUS (AAV) GENE THERAPY MARKET FORECAST
10.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.1.1 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.1.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.1.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2 Americas Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2027-2032)
10.2.1 United States Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2.2 Canada Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2.3 Mexico Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.2.4 Brazil Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3 APAC Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.3.1 China Adeno-Associated Virus (AAV) Gene Therapy Market Forecast
10.3.2 Japan Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.3 Korea Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.4 Southeast Asia Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.5 India Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.3.6 Australia Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Forecast by Country (2027-2032)
10.4.1 Germany Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.2 France Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.3 UK Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.4 Italy Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.4.5 Russia Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Forecast by Region (2027-2032)
10.5.1 Egypt Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5.2 South Africa Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5.3 Israel Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.5.4 Turkey Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
10.6 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Type (2027-2032)
10.7 Global Adeno-Associated Virus (AAV) Gene Therapy Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Adeno-Associated Virus (AAV) Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Information
11.1.2 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Creative Biolabs Main Business Overview
11.1.5 Creative Biolabs Latest Developments
11.2 Affinia Therapeutics
11.2.1 Affinia Therapeutics Company Information
11.2.2 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Affinia Therapeutics Main Business Overview
11.2.5 Affinia Therapeutics Latest Developments
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Information
11.3.2 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Spark Therapeutics Main Business Overview
11.3.5 Spark Therapeutics Latest Developments
11.4 AGC Biologics
11.4.1 AGC Biologics Company Information
11.4.2 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 AGC Biologics Main Business Overview
11.4.5 AGC Biologics Latest Developments
11.5 StrideBio
11.5.1 StrideBio Company Information
11.5.2 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 StrideBio Main Business Overview
11.5.5 StrideBio Latest Developments
11.6 SIRION Biotech
11.6.1 SIRION Biotech Company Information
11.6.2 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 SIRION Biotech Main Business Overview
11.6.5 SIRION Biotech Latest Developments
11.7 Neurophth Biotechnology
11.7.1 Neurophth Biotechnology Company Information
11.7.2 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Neurophth Biotechnology Main Business Overview
11.7.5 Neurophth Biotechnology Latest Developments
11.8 Belief BioMed
11.8.1 Belief BioMed Company Information
11.8.2 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Belief BioMed Main Business Overview
11.8.5 Belief BioMed Latest Developments
11.9 BiBo Biopharma Engineering Co., LTD.
11.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
11.9.2 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 BiBo Biopharma Engineering Co., LTD. Main Business Overview
11.9.5 BiBo Biopharma Engineering Co., LTD. Latest Developments
11.10 Beihai Kangcheng
11.10.1 Beihai Kangcheng Company Information
11.10.2 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Beihai Kangcheng Main Business Overview
11.10.5 Beihai Kangcheng Latest Developments
11.11 PackGene Biotech
11.11.1 PackGene Biotech Company Information
11.11.2 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 PackGene Biotech Main Business Overview
11.11.5 PackGene Biotech Latest Developments
11.12 Sarepta Therapeutics
11.12.1 Sarepta Therapeutics Company Information
11.12.2 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sarepta Therapeutics Main Business Overview
11.12.5 Sarepta Therapeutics Latest Developments
11.13 Carbon BioSciences
11.13.1 Carbon BioSciences Company Information
11.13.2 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Carbon BioSciences Main Business Overview
11.13.5 Carbon BioSciences Latest Developments
11.14 Kelonia Therapeutics
11.14.1 Kelonia Therapeutics Company Information
11.14.2 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Kelonia Therapeutics Main Business Overview
11.14.5 Kelonia Therapeutics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Remedium Bio
11.16.1 Remedium Bio Company Information
11.16.2 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
11.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Remedium Bio Main Business Overview
11.16.5 Remedium Bio Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Adeno-Associated Virus (AAV) Gene Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Luxturna
Table 4. Major Players of Zolgensma
Table 5. Major Players of Others
Table 6. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Table 9. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Table 12. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player (2021-2026)
Table 14. Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
Table 15. Adeno-Associated Virus (AAV) Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Table 20. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2021-2026)
Table 24. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Table 26. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Table 28. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Table 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2021-2026)
Table 34. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus (AAV) Gene Therapy
Table 40. Key Market Challenges & Risks of Adeno-Associated Virus (AAV) Gene Therapy
Table 41. Key Industry Trends of Adeno-Associated Virus (AAV) Gene Therapy
Table 42. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Creative Biolabs Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 47. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 48. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Creative Biolabs Main Business
Table 50. Creative Biolabs Latest Developments
Table 51. Affinia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 52. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 53. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Affinia Therapeutics Main Business
Table 55. Affinia Therapeutics Latest Developments
Table 56. Spark Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 57. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 58. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Spark Therapeutics Main Business
Table 60. Spark Therapeutics Latest Developments
Table 61. AGC Biologics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 62. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 63. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. AGC Biologics Main Business
Table 65. AGC Biologics Latest Developments
Table 66. StrideBio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 67. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 68. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. StrideBio Main Business
Table 70. StrideBio Latest Developments
Table 71. SIRION Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 72. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 73. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. SIRION Biotech Main Business
Table 75. SIRION Biotech Latest Developments
Table 76. Neurophth Biotechnology Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 77. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 78. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Neurophth Biotechnology Main Business
Table 80. Neurophth Biotechnology Latest Developments
Table 81. Belief BioMed Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 82. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 83. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Belief BioMed Main Business
Table 85. Belief BioMed Latest Developments
Table 86. BiBo Biopharma Engineering Co., LTD. Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 87. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 88. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. BiBo Biopharma Engineering Co., LTD. Main Business
Table 90. BiBo Biopharma Engineering Co., LTD. Latest Developments
Table 91. Beihai Kangcheng Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 92. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 93. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Beihai Kangcheng Main Business
Table 95. Beihai Kangcheng Latest Developments
Table 96. PackGene Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 97. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 98. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. PackGene Biotech Main Business
Table 100. PackGene Biotech Latest Developments
Table 101. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 102. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 103. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Sarepta Therapeutics Main Business
Table 105. Sarepta Therapeutics Latest Developments
Table 106. Carbon BioSciences Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 107. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 108. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Carbon BioSciences Main Business
Table 110. Carbon BioSciences Latest Developments
Table 111. Kelonia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 112. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 113. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Kelonia Therapeutics Main Business
Table 115. Kelonia Therapeutics Latest Developments
Table 116. Roche Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 117. Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 118. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Roche Main Business
Table 120. Roche Latest Developments
Table 121. Remedium Bio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 122. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 123. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Remedium Bio Main Business
Table 125. Remedium Bio Latest Developments
Table 1. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Adeno-Associated Virus (AAV) Gene Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Luxturna
Table 4. Major Players of Zolgensma
Table 5. Major Players of Others
Table 6. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Table 9. Adeno-Associated Virus (AAV) Gene Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Table 12. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player (2021-2026)
Table 14. Adeno-Associated Virus (AAV) Gene Therapy Key Players Head office and Products Offered
Table 15. Adeno-Associated Virus (AAV) Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Table 20. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2021-2026)
Table 24. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Table 26. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Table 28. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Table 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country (2021-2026)
Table 34. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Adeno-Associated Virus (AAV) Gene Therapy
Table 40. Key Market Challenges & Risks of Adeno-Associated Virus (AAV) Gene Therapy
Table 41. Key Industry Trends of Adeno-Associated Virus (AAV) Gene Therapy
Table 42. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Creative Biolabs Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 47. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 48. Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Creative Biolabs Main Business
Table 50. Creative Biolabs Latest Developments
Table 51. Affinia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 52. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 53. Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Affinia Therapeutics Main Business
Table 55. Affinia Therapeutics Latest Developments
Table 56. Spark Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 57. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 58. Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Spark Therapeutics Main Business
Table 60. Spark Therapeutics Latest Developments
Table 61. AGC Biologics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 62. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 63. AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. AGC Biologics Main Business
Table 65. AGC Biologics Latest Developments
Table 66. StrideBio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 67. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 68. StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. StrideBio Main Business
Table 70. StrideBio Latest Developments
Table 71. SIRION Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 72. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 73. SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. SIRION Biotech Main Business
Table 75. SIRION Biotech Latest Developments
Table 76. Neurophth Biotechnology Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 77. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 78. Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Neurophth Biotechnology Main Business
Table 80. Neurophth Biotechnology Latest Developments
Table 81. Belief BioMed Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 82. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 83. Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Belief BioMed Main Business
Table 85. Belief BioMed Latest Developments
Table 86. BiBo Biopharma Engineering Co., LTD. Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 87. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 88. BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. BiBo Biopharma Engineering Co., LTD. Main Business
Table 90. BiBo Biopharma Engineering Co., LTD. Latest Developments
Table 91. Beihai Kangcheng Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 92. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 93. Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Beihai Kangcheng Main Business
Table 95. Beihai Kangcheng Latest Developments
Table 96. PackGene Biotech Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 97. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 98. PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. PackGene Biotech Main Business
Table 100. PackGene Biotech Latest Developments
Table 101. Sarepta Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 102. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 103. Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Sarepta Therapeutics Main Business
Table 105. Sarepta Therapeutics Latest Developments
Table 106. Carbon BioSciences Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 107. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 108. Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Carbon BioSciences Main Business
Table 110. Carbon BioSciences Latest Developments
Table 111. Kelonia Therapeutics Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 112. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 113. Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Kelonia Therapeutics Main Business
Table 115. Kelonia Therapeutics Latest Developments
Table 116. Roche Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 117. Roche Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 118. Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Roche Main Business
Table 120. Roche Latest Developments
Table 121. Remedium Bio Details, Company Type, Adeno-Associated Virus (AAV) Gene Therapy Area Served and Its Competitors
Table 122. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product Offered
Table 123. Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Remedium Bio Main Business
Table 125. Remedium Bio Latest Developments
LIST OF FIGURES
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Adeno-Associated Virus (AAV) Gene Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2025)
Figure 8. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2025
Figure 10. Adeno-Associated Virus (AAV) Gene Therapy in Central Nervous System Diseases
Figure 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Central Nervous System Diseases (2021-2026) & ($ millions)
Figure 12. Adeno-Associated Virus (AAV) Gene Therapy in Ocular Diseases
Figure 13. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Ocular Diseases (2021-2026) & ($ millions)
Figure 14. Adeno-Associated Virus (AAV) Gene Therapy in Liver-directed Diseases
Figure 15. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Liver-directed Diseases (2021-2026) & ($ millions)
Figure 16. Adeno-Associated Virus (AAV) Gene Therapy in Other Hereditary Diseases
Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Other Hereditary Diseases (2021-2026) & ($ millions)
Figure 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2025
Figure 19. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player in 2025
Figure 20. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 22. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 23. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Value Market Share by Country in 2025
Figure 26. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region in 2025
Figure 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 33. China Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2025
Figure 40. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 56. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 57. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 59. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 60. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 63. China Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 64. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 65. Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 67. India Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 68. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 69. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 70. France Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 71. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 72. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 73. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 76. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 78. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 1. Adeno-Associated Virus (AAV) Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Adeno-Associated Virus (AAV) Gene Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2025)
Figure 8. Adeno-Associated Virus (AAV) Gene Therapy Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type in 2025
Figure 10. Adeno-Associated Virus (AAV) Gene Therapy in Central Nervous System Diseases
Figure 11. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Central Nervous System Diseases (2021-2026) & ($ millions)
Figure 12. Adeno-Associated Virus (AAV) Gene Therapy in Ocular Diseases
Figure 13. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Ocular Diseases (2021-2026) & ($ millions)
Figure 14. Adeno-Associated Virus (AAV) Gene Therapy in Liver-directed Diseases
Figure 15. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Liver-directed Diseases (2021-2026) & ($ millions)
Figure 16. Adeno-Associated Virus (AAV) Gene Therapy in Other Hereditary Diseases
Figure 17. Global Adeno-Associated Virus (AAV) Gene Therapy Market: Other Hereditary Diseases (2021-2026) & ($ millions)
Figure 18. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application in 2025
Figure 19. Global Adeno-Associated Virus (AAV) Gene Therapy Revenue Market Share by Player in 2025
Figure 20. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 21. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 22. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 23. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2021-2026 ($ millions)
Figure 25. Americas Adeno-Associated Virus (AAV) Gene Therapy Value Market Share by Country in 2025
Figure 26. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region in 2025
Figure 31. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 32. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 33. China Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 37. India Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Country in 2025
Figure 40. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 41. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 42. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 43. France Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 56. APAC Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 57. Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 59. United States Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 60. Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 61. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 62. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 63. China Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 64. Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 65. Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 67. India Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 68. Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 69. Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 70. France Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 71. UK Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 72. Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 73. Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 74. Egypt Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 75. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 76. Israel Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 77. Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
Figure 78. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Adeno-Associated Virus (AAV) Gene Therapy Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market Size 2027-2032 ($ millions)
